Trial
NCT02858843
The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Cystic Fibrosis
Intervention
lumacaftor-ivacaftor
Why stopped
We were unable to enroll eligible subjects for the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-21